A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients IMPACT OF CANCER-DIRECTED TREATMENT

What's the purpose of this trial?

This study assesses the impact of cannabis (also commonly called marijuana, weed, or THC) use on quality of life among patients with multiple myeloma who are receiving chemotherapy. It also evaluates the potential benefits and harms of cannabis use.

This is an upcoming trial that has not yet started accepting patients.

What will happen during the trial?

You may be able to join this trial if you:

The following criteria is a partial list of reasons why patients may be eligible to participate in this clinical trial. Further evaluation with a medical professional is required.

Inclusion Criteria:

* \* Documented informed consent of the participant

* Age: ≥ 18 years
* ECOG ≤ 3
* Ability to read and understand English
* Patient must be newly diagnosed with a histologically confirmed multiple myeloma
* Patients may have started first line therapies and received up to four cycles
* HCP SURVEY: Documented informed consent of the participant
* HCP SURVEY: Age: ≥ 18 years
* HCP SURVEY: Licensed physician, physician assistant, nurse practitioner, or registered nurse
* HCP SURVEY: Currently practicing in oncology or providing direct care to oncology patients
* HCP SURVEY: Able to read and understand English
* HCP SURVEY: Affiliation with City of Hope

Exclusion Criteria:

* \* Patients may not have completed five cycles of first line therapy or undergone any second line therapy

* Other active malignancy
* Patients may not have undergone autologous hematopoietic stem cell transplantation
* Unable to comply with the study assessments
* HCP SURVEY: Reports directly to study PI (Dr. Richard Lee)
* HCP SURVEY: Member of the study team or involved in survey design or analysis
* HCP SURVEY: Individuals with a real or perceived conflict of interest that could bias survey responses

Additional Trial Information

Observational Trial

Enrollment: 700 patients (estimated)

View More
Need Help?

Interested in joining or learning more about this trial?

(888) 828-2206

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.

Arizona

City of Hope

Goodyear, AZ

Not Yet Accepting

California

City of Hope Comprehensive Cancer Center Beckman Research Institute

Duarte, CA

Not Yet Accepting

City of Hope - Seacliff

Huntington Beach, CA

Not Yet Accepting

City of Hope Orange County Lennar Foundation Cancer Center

Irvine, CA

Not Yet Accepting

City of Hope

Long Beach, CA

Not Yet Accepting

City of Hope at Newport Beach Fashion Island

Newport Beach, CA

Not Yet Accepting

City of Hope

South Pasadena, CA

Not Yet Accepting

City of Hope

Upland, CA

Not Yet Accepting

City of Hope

West Covina, CA

Not Yet Accepting

Georgia

City of Hope Atlanta Southeastern Regional Medical Center

Newnan, GA

Not Yet Accepting

Illinois

City of Hope

Zion, IL

Not Yet Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • Add this trial to your favorites keyboard_arrow_right

    If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message